DK610288A - Genteknisk fremstilling af antikoagulerende protein pp4 - Google Patents

Genteknisk fremstilling af antikoagulerende protein pp4

Info

Publication number
DK610288A
DK610288A DK610288A DK610288A DK610288A DK 610288 A DK610288 A DK 610288A DK 610288 A DK610288 A DK 610288A DK 610288 A DK610288 A DK 610288A DK 610288 A DK610288 A DK 610288A
Authority
DK
Denmark
Prior art keywords
genetic
manufacture
anticoagulating protein
anticoagulating
protein
Prior art date
Application number
DK610288A
Other languages
Danish (da)
English (en)
Other versions
DK610288D0 (da
Inventor
Ulrich Grundmann
Karl-Josef Abel
Hans Kuepper
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK610288D0 publication Critical patent/DK610288D0/da
Publication of DK610288A publication Critical patent/DK610288A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK610288A 1987-11-03 1988-11-02 Genteknisk fremstilling af antikoagulerende protein pp4 DK610288A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873737239 DE3737239A1 (de) 1987-11-03 1987-11-03 Gentechnische herstellung von anticoagulatorischem protein pp4

Publications (2)

Publication Number Publication Date
DK610288D0 DK610288D0 (da) 1988-11-02
DK610288A true DK610288A (da) 1989-05-04

Family

ID=6339665

Family Applications (1)

Application Number Title Priority Date Filing Date
DK610288A DK610288A (da) 1987-11-03 1988-11-02 Genteknisk fremstilling af antikoagulerende protein pp4

Country Status (8)

Country Link
EP (1) EP0318703A1 (pt)
JP (1) JPH01165386A (pt)
KR (1) KR890008317A (pt)
AU (1) AU2458988A (pt)
DE (1) DE3737239A1 (pt)
DK (1) DK610288A (pt)
FI (1) FI885024A (pt)
PT (1) PT88912B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO164991C (no) * 1984-09-21 1990-12-05 Boehringer Ingelheim Int Fremgangsmaate for fremstilling av blodkoaguleringshemmende proteiner.
ES2055234T3 (es) * 1989-07-15 1994-08-16 Boehringer Ingelheim Int Agente con contenido de anticoagulante.
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
DE4012341A1 (de) * 1990-04-18 1991-10-24 Behringwerke Ag Monoklonale antikoerper gegen pp4, verfahren zu ihrer herstellung und ihre verwendung
SG46493A1 (en) * 1992-07-08 1998-02-20 Innogenetics Nv Polypepides derived form endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
WO1996015152A1 (fr) * 1994-11-11 1996-05-23 International Reagents Corporation Anticorps monoclonal antiannexine-v, procede pour produire cet anticorps, et utilisation de cet anticorps
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
JP2004528025A (ja) 2001-02-21 2004-09-16 サーロメッド・インコーポレーテッド 修飾されたアネキシン蛋白質及び血栓症を防ぐための方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3315000A1 (de) * 1983-04-26 1984-10-31 Behringwerke Ag, 3550 Marburg Gewebeprotein pp(pfeil abwaerts)4(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
DE10399009I1 (de) * 1984-01-12 2003-10-23 Chiron Corp F}r Faktor-VIIIc kodierende DNA-Sequenzen und verwandte DNA-Konstruktionen
CA1265446A (en) * 1985-09-30 1990-02-06 Masahiro Maki Anticoagulating substance, process for preparing same and anticoagulant comprising same as an effective component
DE3643182A1 (de) * 1986-12-18 1988-06-30 Behringwerke Ag Arzneimittel enthaltend das gewebeprotein pp4, verfahren zur herstellung von pp4 und zu seiner pasteurisierung sowie die verwendung von pp4

Also Published As

Publication number Publication date
FI885024A0 (fi) 1988-11-01
PT88912B (pt) 1993-01-29
EP0318703A1 (de) 1989-06-07
FI885024A (fi) 1989-05-04
JPH01165386A (ja) 1989-06-29
PT88912A (pt) 1988-12-01
DE3737239A1 (de) 1989-10-12
KR890008317A (ko) 1989-07-10
DK610288D0 (da) 1988-11-02
AU2458988A (en) 1989-05-04

Similar Documents

Publication Publication Date Title
IT1182721B (it) Procedimento di purificazione di proteine ossee
NO874357D0 (no) Rensing av pichia-produserte lipofile proteiner.
BR8807722A (pt) Rim artificial implantavel
DK193588A (da) Anvendelser af dopaminagonister
DK275788D0 (da) Protein
DK610288D0 (da) Genteknisk fremstilling af antikoagulerende protein pp4
DK417887D0 (da) Sekretion af heterologe proteiner fra gaer
DE68927061D1 (de) Fassen von juwelen
DK431485A (da) Gensidig adskillelse af proteiner
DK398987D0 (da) Fremgangsmaade til fremstilling af blodprotein
DK549688A (da) Fremstilling af peptider
DK85589D0 (da) Ekspression af hiv-bindende proteiner
DK271588A (da) Genteknologisk fremgangsmaade til fremstilling af angiogeniner
DE3890771T1 (de) Intraokularlinse zur korrektion von ametropie
DK209288A (da) Fraskillelse af aktiveret humant protein c
DK203384A (da) Immobilisering af proteiner
DK562289D0 (da) Anvendelse af somatostatiner
PT88363A (pt) Geerate zur ausgleichung stoerender felder
DK241688D0 (da) Fremgangsmaade til fremstilling af fusionsproteiner
FI881124A (fi) Foerfarande foer extraktion av protein pp4 ur vaevnader och anvaendning av citronsyra foer detta aendamaol.
DK105089A (da) Fremstilling af bis(amin-holdige)benzendioler
DK450087D0 (da) Fremgangsmaade til fremstilling af proteiner
DK512687D0 (da) Fremstilling af proteiner
DK135387D0 (da) Fremstilling af proteiner
DK460987D0 (da) Fremstilling af proteiner.

Legal Events

Date Code Title Description
ATS Application withdrawn